LINC00978	B:C3810893
predicts	O
poor	O
prognosis	I:C0278252
in	O
breast	O
cancer	I:C0678222
patients	O
.	O

LINC00978	O
predicts	O
poor	B:C0278252
prognosis	I:C0278252
in	O
breast	O
cancer	I:C0678222
patients	O
.	O

LINC00978	O
predicts	O
poor	O
prognosis	I:C0278252
in	O
breast	B:C0678222
cancer	I:C0678222
patients	O
.	O

Breast	B:C0678222
cancer	I:C0678222
is	O
the	O
most	O
frequently	O
diagnosed	O
cancer	O
and	O
the	O
leading	O
cause	O
of	O
cancer	O
death	O
among	O
women	O
worldwide	O
.	O

Breast	O
cancer	I:C0678222
is	O
the	O
most	O
frequently	O
diagnosed	B:C0011900
cancer	O
and	O
the	O
leading	O
cause	O
of	O
cancer	O
death	O
among	O
women	O
worldwide	O
.	O

Breast	O
cancer	I:C0678222
is	O
the	O
most	O
frequently	O
diagnosed	O
cancer	B:C0006826
and	O
the	O
leading	O
cause	O
of	O
cancer	O
death	O
among	O
women	O
worldwide	O
.	O

Breast	O
cancer	I:C0678222
is	O
the	O
most	O
frequently	O
diagnosed	O
cancer	O
and	O
the	O
leading	O
cause	O
of	O
cancer	B:C0006826
death	O
among	O
women	O
worldwide	O
.	O

Breast	O
cancer	I:C0678222
is	O
the	O
most	O
frequently	O
diagnosed	O
cancer	O
and	O
the	O
leading	O
cause	O
of	O
cancer	O
death	B:C0011065
among	O
women	O
worldwide	O
.	O

Breast	O
cancer	I:C0678222
is	O
the	O
most	O
frequently	O
diagnosed	O
cancer	O
and	O
the	O
leading	O
cause	O
of	O
cancer	O
death	O
among	O
women	B:C0043210
worldwide	O
.	O

Long	B:C3494264
non-coding	I:C3494264
RNAs	I:C3494264
(	O
Long	O
non-coding	I:C3494264
RNAs	I:C3494264
)	O
are	O
a	O
class	O
of	O
non-coding	O
RNAs	I:C0887909
in	O
the	O
human	O
genome	I:C0017429
that	O
involves	O
in	O
breast	O
cancer	I:C0678222
development	O
and	O
progression	O
.	O

Long	O
non-coding	I:C3494264
RNAs	I:C3494264
(	O
Long	B:C3494264
non-coding	I:C3494264
RNAs	I:C3494264
)	O
are	O
a	O
class	O
of	O
non-coding	O
RNAs	I:C0887909
in	O
the	O
human	O
genome	I:C0017429
that	O
involves	O
in	O
breast	O
cancer	I:C0678222
development	O
and	O
progression	O
.	O

Long	O
non-coding	I:C3494264
RNAs	I:C3494264
(	O
Long	O
non-coding	I:C3494264
RNAs	I:C3494264
)	O
are	O
a	O
class	O
of	O
non-coding	B:C0887909
RNAs	I:C0887909
in	O
the	O
human	O
genome	I:C0017429
that	O
involves	O
in	O
breast	O
cancer	I:C0678222
development	O
and	O
progression	O
.	O

Long	O
non-coding	I:C3494264
RNAs	I:C3494264
(	O
Long	O
non-coding	I:C3494264
RNAs	I:C3494264
)	O
are	O
a	O
class	O
of	O
non-coding	O
RNAs	I:C0887909
in	O
the	O
human	B:C0017429
genome	I:C0017429
that	O
involves	O
in	O
breast	O
cancer	I:C0678222
development	O
and	O
progression	O
.	O

Long	O
non-coding	I:C3494264
RNAs	I:C3494264
(	O
Long	O
non-coding	I:C3494264
RNAs	I:C3494264
)	O
are	O
a	O
class	O
of	O
non-coding	O
RNAs	I:C0887909
in	O
the	O
human	O
genome	I:C0017429
that	O
involves	O
in	O
breast	B:C0678222
cancer	I:C0678222
development	O
and	O
progression	O
.	O

Long	O
non-coding	I:C3494264
RNAs	I:C3494264
(	O
Long	O
non-coding	I:C3494264
RNAs	I:C3494264
)	O
are	O
a	O
class	O
of	O
non-coding	O
RNAs	I:C0887909
in	O
the	O
human	O
genome	I:C0017429
that	O
involves	O
in	O
breast	O
cancer	I:C0678222
development	O
and	O
progression	B:C0242656
.	O

Here	O
,	O
we	O
identify	O
a	O
lncRNA	B:C3494264
,	O
LINC00978	O
,	O
which	O
is	O
upregulated	O
in	O
breast	O
cancer	I:C0678222
cell	O
lines	I:C0007600
and	O
tissues	O
compared	O
with	O
corresponding	O
controls	O
.	O

Here	O
,	O
we	O
identify	O
a	O
lncRNA	O
,	O
LINC00978	B:C3810893
,	O
which	O
is	O
upregulated	O
in	O
breast	O
cancer	I:C0678222
cell	O
lines	I:C0007600
and	O
tissues	O
compared	O
with	O
corresponding	O
controls	O
.	O

Here	O
,	O
we	O
identify	O
a	O
lncRNA	O
,	O
LINC00978	O
,	O
which	O
is	O
upregulated	O
in	O
breast	B:C0678222
cancer	I:C0678222
cell	O
lines	I:C0007600
and	O
tissues	O
compared	O
with	O
corresponding	O
controls	O
.	O

Here	O
,	O
we	O
identify	O
a	O
lncRNA	O
,	O
LINC00978	O
,	O
which	O
is	O
upregulated	O
in	O
breast	O
cancer	I:C0678222
cell	B:C0007600
lines	I:C0007600
and	O
tissues	O
compared	O
with	O
corresponding	O
controls	O
.	O

Here	O
,	O
we	O
identify	O
a	O
lncRNA	O
,	O
LINC00978	O
,	O
which	O
is	O
upregulated	O
in	O
breast	O
cancer	I:C0678222
cell	O
lines	I:C0007600
and	O
tissues	B:C0040300
compared	O
with	O
corresponding	O
controls	O
.	O

Furthermore	O
,	O
LINC00978	B:C3810893
expression	O
is	O
negatively	O
associated	O
with	O
hormone	O
receptor	I:C0019929
(	O
hormone	O
receptor	I:C0019929
)	O
status	O
in	O
195	O
breast	O
cancer	I:C0678222
patients	O
studied	O
(	O
p	O
=	O
0.033	O
)	O
.	O

Furthermore	O
,	O
LINC00978	O
expression	B:C0017262
is	O
negatively	O
associated	O
with	O
hormone	O
receptor	I:C0019929
(	O
hormone	O
receptor	I:C0019929
)	O
status	O
in	O
195	O
breast	O
cancer	I:C0678222
patients	O
studied	O
(	O
p	O
=	O
0.033	O
)	O
.	O

Furthermore	O
,	O
LINC00978	O
expression	O
is	O
negatively	B:C1513916
associated	O
with	O
hormone	O
receptor	I:C0019929
(	O
hormone	O
receptor	I:C0019929
)	O
status	O
in	O
195	O
breast	O
cancer	I:C0678222
patients	O
studied	O
(	O
p	O
=	O
0.033	O
)	O
.	O

Furthermore	O
,	O
LINC00978	O
expression	O
is	O
negatively	O
associated	O
with	O
hormone	B:C0019929
receptor	I:C0019929
(	O
hormone	O
receptor	I:C0019929
)	O
status	O
in	O
195	O
breast	O
cancer	I:C0678222
patients	O
studied	O
(	O
p	O
=	O
0.033	O
)	O
.	O

Furthermore	O
,	O
LINC00978	O
expression	O
is	O
negatively	O
associated	O
with	O
hormone	O
receptor	I:C0019929
(	O
hormone	B:C0019929
receptor	I:C0019929
)	O
status	O
in	O
195	O
breast	O
cancer	I:C0678222
patients	O
studied	O
(	O
p	O
=	O
0.033	O
)	O
.	O

Furthermore	O
,	O
LINC00978	O
expression	O
is	O
negatively	O
associated	O
with	O
hormone	O
receptor	I:C0019929
(	O
hormone	O
receptor	I:C0019929
)	O
status	O
in	O
195	O
breast	B:C0678222
cancer	I:C0678222
patients	O
studied	O
(	O
p	O
=	O
0.033	O
)	O
.	O

Kaplan	O
-	O
Meier	O
survival	O
analysis	O
shows	O
that	O
patients	O
with	O
high	O
LINC00978	B:C3810893
expression	O
have	O
poorer	O
disease	O
-	O
free	O
survival	O
(	O
DFS	O
)	O
than	O
those	O
with	O
low	O
LINC00978	O
expression	O
(	O
p	O
=	O
0.012	O
)	O
,	O
and	O
multivariate	O
analysis	O
identifies	O
LINC00978	O
as	O
an	O
independent	O
prognostic	O
factor	I:C1514474
in	O
breast	O
cancer	I:C0678222
(	O
p	O
=	O
0.008	O
,	O
hazard	O
ratio	O
[	O
HR	O
]	O
=	O
2.270	O
,	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
]	O
1.237-4.165	O
)	O
.	O

Kaplan	O
-	O
Meier	O
survival	O
analysis	O
shows	O
that	O
patients	O
with	O
high	O
LINC00978	O
expression	B:C0017262
have	O
poorer	O
disease	O
-	O
free	O
survival	O
(	O
DFS	O
)	O
than	O
those	O
with	O
low	O
LINC00978	O
expression	O
(	O
p	O
=	O
0.012	O
)	O
,	O
and	O
multivariate	O
analysis	O
identifies	O
LINC00978	O
as	O
an	O
independent	O
prognostic	O
factor	I:C1514474
in	O
breast	O
cancer	I:C0678222
(	O
p	O
=	O
0.008	O
,	O
hazard	O
ratio	O
[	O
HR	O
]	O
=	O
2.270	O
,	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
]	O
1.237-4.165	O
)	O
.	O

Kaplan	O
-	O
Meier	O
survival	O
analysis	O
shows	O
that	O
patients	O
with	O
high	O
LINC00978	O
expression	O
have	O
poorer	O
disease	O
-	O
free	O
survival	O
(	O
DFS	O
)	O
than	O
those	O
with	O
low	O
LINC00978	B:C3810893
expression	O
(	O
p	O
=	O
0.012	O
)	O
,	O
and	O
multivariate	O
analysis	O
identifies	O
LINC00978	O
as	O
an	O
independent	O
prognostic	O
factor	I:C1514474
in	O
breast	O
cancer	I:C0678222
(	O
p	O
=	O
0.008	O
,	O
hazard	O
ratio	O
[	O
HR	O
]	O
=	O
2.270	O
,	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
]	O
1.237-4.165	O
)	O
.	O

Kaplan	O
-	O
Meier	O
survival	O
analysis	O
shows	O
that	O
patients	O
with	O
high	O
LINC00978	O
expression	O
have	O
poorer	O
disease	O
-	O
free	O
survival	O
(	O
DFS	O
)	O
than	O
those	O
with	O
low	O
LINC00978	O
expression	B:C0017262
(	O
p	O
=	O
0.012	O
)	O
,	O
and	O
multivariate	O
analysis	O
identifies	O
LINC00978	O
as	O
an	O
independent	O
prognostic	O
factor	I:C1514474
in	O
breast	O
cancer	I:C0678222
(	O
p	O
=	O
0.008	O
,	O
hazard	O
ratio	O
[	O
HR	O
]	O
=	O
2.270	O
,	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
]	O
1.237-4.165	O
)	O
.	O

Kaplan	O
-	O
Meier	O
survival	O
analysis	O
shows	O
that	O
patients	O
with	O
high	O
LINC00978	O
expression	O
have	O
poorer	O
disease	O
-	O
free	O
survival	O
(	O
DFS	O
)	O
than	O
those	O
with	O
low	O
LINC00978	O
expression	O
(	O
p	O
=	O
0.012	O
)	O
,	O
and	O
multivariate	O
analysis	O
identifies	O
LINC00978	B:C3810893
as	O
an	O
independent	O
prognostic	O
factor	I:C1514474
in	O
breast	O
cancer	I:C0678222
(	O
p	O
=	O
0.008	O
,	O
hazard	O
ratio	O
[	O
HR	O
]	O
=	O
2.270	O
,	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
]	O
1.237-4.165	O
)	O
.	O

Kaplan	O
-	O
Meier	O
survival	O
analysis	O
shows	O
that	O
patients	O
with	O
high	O
LINC00978	O
expression	O
have	O
poorer	O
disease	O
-	O
free	O
survival	O
(	O
DFS	O
)	O
than	O
those	O
with	O
low	O
LINC00978	O
expression	O
(	O
p	O
=	O
0.012	O
)	O
,	O
and	O
multivariate	O
analysis	O
identifies	O
LINC00978	O
as	O
an	O
independent	O
prognostic	B:C1514474
factor	I:C1514474
in	O
breast	O
cancer	I:C0678222
(	O
p	O
=	O
0.008	O
,	O
hazard	O
ratio	O
[	O
HR	O
]	O
=	O
2.270	O
,	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
]	O
1.237-4.165	O
)	O
.	O

Kaplan	O
-	O
Meier	O
survival	O
analysis	O
shows	O
that	O
patients	O
with	O
high	O
LINC00978	O
expression	O
have	O
poorer	O
disease	O
-	O
free	O
survival	O
(	O
DFS	O
)	O
than	O
those	O
with	O
low	O
LINC00978	O
expression	O
(	O
p	O
=	O
0.012	O
)	O
,	O
and	O
multivariate	O
analysis	O
identifies	O
LINC00978	O
as	O
an	O
independent	O
prognostic	O
factor	I:C1514474
in	O
breast	B:C0678222
cancer	I:C0678222
(	O
p	O
=	O
0.008	O
,	O
hazard	O
ratio	O
[	O
HR	O
]	O
=	O
2.270	O
,	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
]	O
1.237-4.165	O
)	O
.	O

Our	O
study	O
indicates	O
that	O
LINC00978	B:C3810893
may	O
be	O
an	O
oncogene	O
in	O
breast	O
cancer	I:C0678222
,	O
and	O
can	O
serve	O
as	O
a	O
potential	O
biomarker	O
to	O
predict	O
prognosis	O
in	O
breast	O
cancer	I:C0678222
patients	O
.	O

Our	O
study	O
indicates	O
that	O
LINC00978	O
may	O
be	O
an	O
oncogene	B:C0029016
in	O
breast	O
cancer	I:C0678222
,	O
and	O
can	O
serve	O
as	O
a	O
potential	O
biomarker	O
to	O
predict	O
prognosis	O
in	O
breast	O
cancer	I:C0678222
patients	O
.	O

Our	O
study	O
indicates	O
that	O
LINC00978	O
may	O
be	O
an	O
oncogene	O
in	O
breast	B:C0678222
cancer	I:C0678222
,	O
and	O
can	O
serve	O
as	O
a	O
potential	O
biomarker	O
to	O
predict	O
prognosis	O
in	O
breast	O
cancer	I:C0678222
patients	O
.	O

Our	O
study	O
indicates	O
that	O
LINC00978	O
may	O
be	O
an	O
oncogene	O
in	O
breast	O
cancer	I:C0678222
,	O
and	O
can	O
serve	O
as	O
a	O
potential	O
biomarker	B:C0005516
to	O
predict	O
prognosis	O
in	O
breast	O
cancer	I:C0678222
patients	O
.	O

Our	O
study	O
indicates	O
that	O
LINC00978	O
may	O
be	O
an	O
oncogene	O
in	O
breast	O
cancer	I:C0678222
,	O
and	O
can	O
serve	O
as	O
a	O
potential	O
biomarker	O
to	O
predict	O
prognosis	B:C0033325
in	O
breast	O
cancer	I:C0678222
patients	O
.	O

Our	O
study	O
indicates	O
that	O
LINC00978	O
may	O
be	O
an	O
oncogene	O
in	O
breast	O
cancer	I:C0678222
,	O
and	O
can	O
serve	O
as	O
a	O
potential	O
biomarker	O
to	O
predict	O
prognosis	O
in	O
breast	B:C0678222
cancer	I:C0678222
patients	O
.	O

